International speakers include:

Revolutionise Genomic Research, Implement a Cost Effective Approach, Transform Data into Knowledge

Next Generation DNA Sequencing 2011, Pharma IQ’s 2nd annual event hosted following the success of last years launch, brings you the latest updates, best practice methods and innovative breakthroughs to keep you at the forefront of genomic research.

This March join us in London with our expert panel of international speakers as they set the standards for the coming year’s developments. With the commercialisation of genome sequencing pushing investment in research to further heights you can never be at the forefront of industry progressions until you are networking, benchmarking and exchanging information with industry leaders.

Case studies from academia and bio-pharma will compare current case studies and sequencers with existing microarray and other genotyping analysis tools. Assessing current technology based on sensitivity, reliability, reproducibility, cost and time to results.

Join your colleagues to discuss how to:

  • Choose the right technology for your research projects
  • Accurately scan and identify rare variants in genes, short sequence repeats and mutations early on.
  • Extract DNA from difficult samples
  • Develop robust diagnostic tests and learn how Next-Generation Sequencers are enabling suitable tests for clinical application

Why is Pharma IQ’s Next Generation DNA Sequencing a 2011’s Must-Attend?

1. Improve your methodology and productivity by implementing best practice strategies across the board with methods trialed in large biopharma labs by Bhupinder Bhullar, Novartis AG

2. Implement the most suitable technology to your business to ensure correct investment and allow technological scalability in a discussion with Jeff Schloss, NHGRI, National Institute of Health

3. Resolve your data management issues with a look into the measures available for data transfer, storage and archiving as practiced in the European Bioinformatics Institute with Guy Cochrane

4. Transform your data into usable knowledge and ensure more data is more knowledge by using the right bioinformatics tools. Jessica Vamathevan, GlaxoSmithKline

5. Progress from basic lab research and analysis to clinical application and learn about the latest case studies currently undertaken at the Beijing Genomics Institute and the Wellcome Trust Sanger Institute

This meeting, amongst users of the technology, is important to learn the solutions to the problems in the applications of next-gen technology and really helps me develop our internal processes.
Dr Bhupinder Bhullar, Novartis Pharma AG
Next generation sequencing technology will undoubtedly change the medical field by giving us the genomic information needed for accurate diagnosis and personalized medicine. I look forward to discussing the implementation of this technology with world leaders in the field this January in London.
Dr Joris Veltman, Radboud University Nijmegen Medical Centre
Sponsor Gold Exhibitors
bgi Animated_sponsors
Media Partners
Animated_Media_new

[ Register Now ]